What is LOPJLB’s current signal on NRXS?

LOPJLB’s latest quantitative signal on NeurAxis, Inc. (NRXS) is SELL in a RECOVERY regime. Signals are updated daily.

What market regime is NRXS in?

NeurAxis, Inc. (NRXS) is currently classified in the RECOVERY HMM market regime on LOPJLB.

What does NeurAxis, Inc. (NRXS) do?

NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. Th…

NeurAxis, Inc. (NRXS)

COMPARE

Healthcare · Biotechnology · AMEX · US

$6.50-3.27%Close

SELLRECOVERY · day 20

Company news

defenseworld.net · 2d ago

Reviewing NeurAxis (NASDAQ:NRXS) and NovoCure (NASDAQ:NVCR)

defenseworld.net · 10d ago

Financial Review: Solventum (NYSE:SOLV) vs. NeurAxis (NASDAQ:NRXS)

globenewswire.com · 16d ago

NeurAxis Positions for Next Phase of Commercial Growth with Appointment of Craig Blanchard as Chief Commercial Officer

defenseworld.net · 24d ago

Financial Review: NeurAxis (NASDAQ:NRXS) & MariMed (OTCMKTS:MRMD)

globenewswire.com · 29d ago

NeurAxis Announces Medical Coverage Policy Milestone, Expanding Access to Over 18 million additional Covered Lives

globenewswire.com · 29d ago

NeurAxis to Participate in the Lytham Partners Fall 2026 Investor Conference

zacks.com · 29d ago

Neuraxis Gains Nearly 137% in a Year: What's Driving the Stock?

seekingalpha.com · 29d ago

NeurAxis, Inc. (NRXS) Presents at IAccess Alpha Virtual Best Ideas Fall Investment Conference 2026 Transcript

zacks.com · 33d ago

Is Kodak having a "Kodak moment?" 2 watchlist stocks.

zacks.com · 61d ago

NRXS Stock Dips Post Q2 Earnings Despite Revenue Surge, Gross Margin Up

seekingalpha.com · 64d ago

NeurAxis, Inc. (NRXS) Q2 2026 Earnings Call Transcript

globenewswire.com · 72d ago

NeurAxis Expands Payer Coverage with New Policies

globenewswire.com · 79d ago

NeurAxis to Host Second Quarter 2026 Results and Business Update Call on Tuesday, August 11, 2026

Market news & ticker search · RSS for NRXS

FAQ

What is LOPJLB’s current signal on NRXS?: LOPJLB’s latest quantitative signal on NeurAxis, Inc. (NRXS) is SELL in a RECOVERY regime. Signals are updated daily.
What market regime is NRXS in?: NeurAxis, Inc. (NRXS) is currently classified in the RECOVERY HMM market regime on LOPJLB.
What does NeurAxis, Inc. (NRXS) do?: NeurAxis, Inc. (NRXS) is an American company specializing in neuromodulation therapy devices. Its primary offering is IB-Stim, a percutaneous electrical nerve field stimulation system engineered to alleviate functional abdominal pain associated with irritable bowel syndrome in patients aged 11 to 18. NeurAxis markets its solutions to healthcare providers, predominantly hospitals and clinics. Th…

NeurAxis, Inc. (NRXS)

Key stats

Prediction markets

Company news

FAQ